Conclusive Results: Strategies for Collecting Quality Data in Psychiatric Clinical Trials

Ensuring that psychiatry clinical trial data accurately captures a compound’s safety and efficacy potential requires an approach that accounts for challenges inherent in working with a mentally ill population. Observing changes in the disease under study is partly a subjective process, and that creates risk of undue influence that the patient and/or investigator may not recognize.

This webinar will examine these factors, with particular focus on:

  • Study design considerations
  • Site factors
  • Subject selection and eligibility
  • Data surveillance

REGISTER

Title: Conclusive Results: Strategies for Collecting Quality Data in Psychiatric Clinical Trials

Date: Tuesday, September 20, 2016

Time: 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)

Speakers:

Phone Us Now
Email Us Now